Literature DB >> 15933813

Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas.

Martin R Graf1, Jeremy T Sauer, Randall E Merchant.   

Abstract

We have recently reported that activation of tumor-specific T cells by subcutaneous vaccination with irradiated T9 glioma cells of syngeneic rats with a pre-existing, intracranial (i.c.) T9 glioma (T9+vaccination) promotes the mobilization of myeloid suppressor cells (MSC) which inhibit T cell function resulting in unregulated tumor progression. The current study investigated if this immunological paradigm could be recapitulated in T cell deficient rats, in other rat glioma models or using a dendritic cell (DC) vaccine. When nude rats were used in the T9+vaccination model, the level of MSC tumor infiltration remained low in vaccinated and control groups and there was no significant difference in tumor size between the groups. Increased tumor infiltration by MSC after vaccination with respective irradiated tumor cells was observed in the 9L, F98 and D74 gliomas. RT-2 tumors were markedly infiltrated with MSC regardless of vaccination. Enhanced tumor progression in response to immunization and T cell activation was observed in rats bearing F98 and D74 gliomas, although less pronounced than in the T9 model, and there was a trend for increased tumor size in the 9L glioma model. Increased MSC infiltrate and augmented T9 glioma growth were observed when DC pulsed with T9 cell lysate was used as a vaccine. These results suggest that MSC infiltration and unregulated tumor growth in response to vaccination is T cell-dependent; is not unique to the T9 glioma; and can be recapitulated with an alternate immunization approach.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15933813     DOI: 10.1007/s11060-007-9442-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.506


  34 in total

1.  Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes.

Authors:  E Apolloni; V Bronte; A Mazzoni; P Serafini; A Cabrelle; D M Segal; H A Young; P Zanovello
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

2.  Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

Authors:  Alessandra Mazzoni; Vincenzo Bronte; Alberto Visintin; Jessica H Spitzer; Elisa Apolloni; Paolo Serafini; Paola Zanovello; David M Segal
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

Review 3.  Dendritic cell based tumor vaccines.

Authors:  M Nouri-Shirazi; J Banchereau; J Fay; K Palucka
Journal:  Immunol Lett       Date:  2000-09-15       Impact factor: 3.685

4.  Transplacental production with ethylnitrosourea of neoplasms of the nervous system in Sprague-Dawley rats.

Authors:  A Koestner; J A Swenberg; W Wechsler
Journal:  Am J Pathol       Date:  1971-04       Impact factor: 4.307

5.  Immunosuppression induced by attenuated Salmonella. Evidence for mediation by macrophage precursors.

Authors:  B K al-Ramadi; M A Brodkin; D M Mosser; T K Eisenstein
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

Review 6.  Progress in active-specific immunotherapy of brain malignancies.

Authors:  B A Tjoa; M L Salgaller
Journal:  Expert Opin Investig Drugs       Date:  2000-09       Impact factor: 6.206

Review 7.  Cancer vaccines: an update.

Authors:  J D Hipp; J A Hipp; B W Lyday; B R Minev
Journal:  In Vivo       Date:  2000 Sep-Oct       Impact factor: 2.155

8.  Myelopoiesis-associated suppressor-cell activity in mice with Lewis lung carcinoma tumors: interferon-gamma plus tumor necrosis factor-alpha synergistically reduce suppressor cell activity.

Authors:  M R Young; M E Young; M A Wright
Journal:  Int J Cancer       Date:  1990-08-15       Impact factor: 7.396

9.  Contrasting effects of interleukin-2 secretion by rat glioma cells contingent upon anatomical location: accelerated tumorigenesis in the central nervous system and complete rejection in the periphery.

Authors:  Martin R Graf; Robert M Prins; Gail A Poulsen; Randall E Merchant
Journal:  J Neuroimmunol       Date:  2003-07       Impact factor: 3.478

10.  Tumor-specific transplantation immunity to intracerebral challenge with cells from a methylnitrosourea- induced brain tumor.

Authors:  R H Denlinger; D A Axler; A Koestner; L Liss
Journal:  J Med       Date:  1975
View more
  6 in total

1.  Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model.

Authors:  Wentao Jia; Colleen Jackson-Cook; Martin R Graf
Journal:  J Neuroimmunol       Date:  2010-05-08       Impact factor: 3.478

2.  Effects of syngeneic cellular vaccinations alone or in combination with GM-CSF on the weakly immunogenic F98 glioma model.

Authors:  Anne Clavreul; Manuel Delhaye; Eric Jadaud; Philippe Menei
Journal:  J Neurooncol       Date:  2006-03-31       Impact factor: 4.130

3.  Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties.

Authors:  Jennifer C Rodrigues; Guido C Gonzalez; Lei Zhang; George Ibrahim; John J Kelly; Michael P Gustafson; Yi Lin; Allan B Dietz; Peter A Forsyth; V Wee Yong; Ian F Parney
Journal:  Neuro Oncol       Date:  2009-12-22       Impact factor: 12.300

4.  Guidelines for the welfare and use of animals in cancer research.

Authors:  P Workman; E O Aboagye; F Balkwill; A Balmain; G Bruder; D J Chaplin; J A Double; J Everitt; D A H Farningham; M J Glennie; L R Kelland; V Robinson; I J Stratford; G M Tozer; S Watson; S R Wedge; S A Eccles
Journal:  Br J Cancer       Date:  2010-05-25       Impact factor: 7.640

5.  CD4+ and Perivascular Foxp3+ T Cells in Glioma Correlate with Angiogenesis and Tumor Progression.

Authors:  Luyan Mu; Changlin Yang; Qiang Gao; Yu Long; Haitao Ge; Gabriel DeLeon; Linchun Jin; Yifan Emily Chang; Elias J Sayour; Jingjing Ji; Jie Jiang; Paul S Kubilis; Jiping Qi; Yunhe Gu; Jiabin Wang; Yuwen Song; Duane A Mitchell; Zhiguo Lin; Jianping Huang
Journal:  Front Immunol       Date:  2017-11-07       Impact factor: 7.561

6.  Therapeutic vaccines for malignant brain tumors.

Authors:  Michael P Gustafson; Keith L Knutson; Allan B Dietz
Journal:  Biologics       Date:  2008-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.